Table 2.
Molecular targets used in this work, with number of active and inactive compounds in total, and in each cell line GES dataset.
Gene name | Total inactive | Total active | Description | A375 | A549 | HA1E | HCC515 | HT29 | MCF7 | PC3 | VCAP | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inactive | Active | Inactive | Active | Inactive | Active | Inactive | Active | Inactive | Active | Inactive | Active | Inactive | Active | Inactive | Active | ||||
ABCB1 | 801 | 96 | ATP binding cassette subfamily B member 1 [HGNC:40] | 331 | 42 | 545 | 60 | 424 | 50 | 211 | 32 | 317 | 32 | 770 | 95 | 772 | 95 | 608 | 68 |
ABHD5 | 2,458 | 57 | Abhydrolase domain containing 5 [HGNC:21396] | 908 | 22 | 1,533 | 47 | - | - | - | - | - | - | 2,030 | 57 | 2,045 | 57 | 1,730 | 52 |
ALOX15 | 1,136 | 101 | Arachidonate 15-lipoxygenase [HGNC:433] | 508 | 27 | 764 | 92 | 808 | 52 | 496 | 33 | 498 | 27 | 1,062 | 97 | 1,066 | 96 | 804 | 91 |
AR | 1,085 | 103 | Androgen receptor [HGNC:644] | 580 | 36 | 639 | 64 | 757 | 62 | 374 | 36 | 572 | 37 | 1,038 | 94 | 1,036 | 93 | 682 | 69 |
ATAD5 | 2,213 | 97 | Atpase family, AAA domain containing 5 [HGNC:25,752] | 1,007 | 43 | 1,466 | 70 | 1288 | 60 | 638 | 41 | 922 | 42 | 2,087 | 90 | 2,090 | 88 | 1,629 | 72 |
ATXN2 | 1,897 | 143 | Ataxin 2 [HGNC:10555] | 695 | 36 | 1,139 | 104 | 950 | 50 | 501 | 41 | 652 | 41 | 1556 | 123 | 1,558 | 129 | 1,243 | 102 |
BAZ2B | 1,252 | 143 | Bromodomain adjacent to zinc finger domain 2B [HGNC:963] | 516 | 63 | 873 | 101 | 653 | 76 | 319 | 37 | 470 | 56 | 1,199 | 135 | 1,197 | 136 | 974 | 112 |
BRCA1 | 3,008 | 160 | BRCA1, dna repair associated [HGNC:1100] | 1,117 | 67 | 1945 | 116 | 1,519 | 63 | 800 | 33 | 1,014 | 50 | 2,537 | 148 | 2,549 | 150 | 2,134 | 131 |
CBX1 | 1,999 | 80 | Chromobox 1 [HGNC:1551] | 899 | 41 | 1,412 | 64 | 1,120 | 61 | 532 | 38 | 809 | 40 | 1,899 | 75 | 1,904 | 76 | 1,576 | 67 |
CHRM1 | 2,433 | 86 | Cholinergic receptor muscarinic 1 [HGNC:1950] | 906 | 49 | 1,544 | 62 | 1,055 | 59 | 460 | 39 | 791 | 48 | 2,036 | 84 | 2051 | 83 | 1,739 | 65 |
CHRM4 | 2,476 | 70 | Cholinergic receptor muscarinic 4 [HGNC:1953] | 908 | 45 | 1,552 | 54 | 1,057 | 55 | 460 | 40 | 793 | 45 | 2,049 | 68 | 2,064 | 67 | 1,751 | 54 |
CHRM5 | 2,478 | 62 | Cholinergic receptor muscarinic 5 [HGNC:1954] | 908 | 41 | 1,553 | 47 | 1,057 | 49 | 461 | 36 | 793 | 39 | 2,050 | 62 | 2,065 | 61 | 1,751 | 50 |
CYP1A2 | 307 | 526 | Cytochrome P450 family 1 subfamily A member 2 [HGNC:2596] | 145 | 265 | 183 | 399 | 219 | 428 | 136 | 277 | 144 | 261 | 299 | 505 | 294 | 505 | 183 | 410 |
CYP2C19 | 717 | 276 | Cytochrome P450 family 2 subfamily C member 19 [HGNC:2621] | 329 | 151 | 514 | 213 | 486 | 228 | 289 | 138 | 324 | 148 | 688 | 271 | 684 | 272 | 524 | 225 |
CYP2C9 | 708 | 270 | Cytochrome P450 family 2 subfamily C member 9 [HGNC:2623] | 310 | 157 | 510 | 197 | 476 | 222 | 285 | 126 | 305 | 154 | 679 | 264 | 674 | 263 | 517 | 207 |
CYP3A4 | 1,153 | 164 | Cytochrome P450 family 3 subfamily A member 4 [HGNC:2637] | 472 | 113 | 780 | 104 | 847 | 133 | 561 | 64 | 467 | 110 | 1,070 | 160 | 1069 | 161 | 802 | 118 |
DRD1 | 1,843 | 99 | Dopamine receptor D1 [HGNC:3020] | 807 | 54 | 1,295 | 71 | 1028 | 78 | 526 | 55 | 725 | 54 | 1,762 | 91 | 1,762 | 91 | 1,450 | 71 |
DRD2 | 2,262 | 95 | Dopamine receptor D2 [HGNC:3023] | 769 | 58 | 1,371 | 73 | 956 | 84 | 474 | 55 | 683 | 57 | 1,858 | 93 | 1873 | 93 | 1,541 | 74 |
DRD3 | 2,446 | 142 | Dopamine receptor D3 [HGNC:3024] | 877 | 76 | 1,432 | 110 | 1,129 | 114 | 551 | 78 | 823 | 75 | 2,004 | 139 | 2,017 | 139 | 1,569 | 111 |
EPAS1 | 2,443 | 70 | Endothelial PAS domain protein 1 [HGNC:3374] | – | – | 1,524 | 52 | – | – | – | – | – | – | 2,021 | 64 | 2,033 | 67 | 1,723 | 57 |
FEN1 | 2,100 | 53 | Flap structure-specific endonuclease 1 [HGNC:3650] | 961 | 23 | 1,496 | 29 | 1,213 | 28 | – | – | 866 | 21 | 1,990 | 46 | 1,999 | 46 | 1,669 | 32 |
GFER | 1,589 | 89 | Growth factor, augmenter of liver regeneration [HGNC:4236] | 679 | 37 | 1,153 | 59 | 813 | 46 | 363 | 21 | 600 | 29 | 1,519 | 81 | 1,519 | 81 | 1,294 | 70 |
GLS | 2,989 | 66 | Glutaminase [HGNC:4331] | 1,240 | 22 | 1,878 | 46 | 1,515 | 31 | – | – | – | – | 2,560 | 58 | 2,574 | 59 | 2,072 | 53 |
GMNN | 2,079 | 161 | Geminin, DNA replication inhibitor [HGNC:17493] | 969 | 67 | 1,392 | 121 | 1,224 | 72 | 569 | 43 | 884 | 63 | 1,972 | 146 | 1,974 | 153 | 1,552 | 128 |
HPGD | 1,464 | 92 | 15-Hydroxyprostaglandin dehydrogenase [HGNC:5154] | 575 | 38 | 1,000 | 74 | 962 | 62 | 618 | 39 | 567 | 37 | 1363 | 89 | 1,363 | 86 | 1,060 | 71 |
HSD17B10 | 1,211 | 107 | Hydroxysteroid 17-beta dehydrogenase 10 [HGNC:4800] | 516 | 48 | 827 | 84 | 858 | 81 | 548 | 47 | 506 | 48 | 1,134 | 99 | 1,135 | 95 | 866 | 81 |
HSP90AA1 | 666 | 56 | Heat shock protein 90 alpha family class A member 1 [HGNC:5253] | 295 | 25 | 453 | 39 | 419 | 38 | – | – | 288 | 25 | 640 | 50 | 637 | 50 | 502 | 40 |
HSPB1 | 876 | 76 | Heat shock protein family B (small) member 1 [HGNC:5246] | 461 | 40 | 522 | 45 | 600 | 53 | 304 | 26 | 454 | 41 | 837 | 72 | 837 | 71 | 558 | 47 |
HTR1A | 412 | 60 | 5-Hydroxytryptamine receptor 1A [HGNC:5286] | 186 | 34 | 279 | 49 | 232 | 55 | 122 | 37 | 180 | 34 | 401 | 58 | 400 | 58 | 315 | 50 |
IL1B | 1,773 | 206 | Interleukin 1 beta [HGNC:5992] | 589 | 54 | 1,005 | 165 | 768 | 78 | 382 | 54 | 541 | 54 | 1,385 | 190 | 1,391 | 196 | 1,122 | 163 |
JAK2 | 895 | 80 | Janus kinase 2 [HGNC:6192] | 378 | 39 | 663 | 58 | 478 | 43 | 248 | 29 | 364 | 40 | 867 | 71 | 867 | 74 | 723 | 55 |
JUN | 842 | 97 | Jun proto-oncogene, AP-1 transcription factor subunit [HGNC:6204] | 442 | 49 | 491 | 67 | 570 | 72 | 279 | 41 | 435 | 49 | 801 | 91 | 799 | 91 | 523 | 70 |
KCNH2 | 363 | 190 | Potassium voltage-gated channel subfamily H member 2 [HGNC:6251] | 174 | 119 | 212 | 136 | 250 | 161 | 128 | 104 | 173 | 119 | 331 | 183 | 329 | 184 | 228 | 139 |
KDM4A | 1,607 | 192 | Lysine demethylase 4A [HGNC:22978] | 693 | 76 | 1,130 | 125 | 834 | 87 | 379 | 42 | 603 | 69 | 1,529 | 173 | 1,536 | 175 | 1,286 | 140 |
KDM4E | 1,389 | 124 | Lysine demethylase 4E [HGNC:37098] | 543 | 43 | 999 | 88 | 880 | 70 | 547 | 40 | 530 | 42 | 1,320 | 109 | 1,321 | 110 | 1,057 | 95 |
MITF | 3,626 | 132 | Melanogenesis associated transcription factor [HGNC:7105] | 1,170 | 42 | 2,238 | 91 | 1,562 | 51 | 858 | 42 | 1,083 | 37 | 2,832 | 116 | 2,871 | 120 | 2,460 | 93 |
MLLT3 | 14,566 | 101 | MLLT3, super elongation complex subunit [HGNC:7136] | – | – | 2,244 | 26 | – | – | – | – | – | – | 3,002 | 33 | 3,461 | 50 | 3,095 | 46 |
MPHOSPH8 | 506 | 52 | M-Phase phosphoprotein 8 [HGNC:29810] | 278 | 21 | 365 | 39 | 403 | 41 | 253 | 29 | 278 | 21 | 490 | 48 | 485 | 50 | 382 | 43 |
MYC | 2,069 | 121 | MYC proto-oncogene, bHLH transcription factor [HGNC:7553] | – | – | 1,067 | 113 | – | – | – | – | – | – | 1,230 | 114 | 1,249 | 117 | 1,151 | 115 |
NFE2L2 | 2,850 | 226 | Nuclear factor, erythroid 2 like 2 [HGNC:7782] | 1,142 | 94 | 1,816 | 148 | 1,355 | 153 | 620 | 83 | 1,013 | 95 | 2,425 | 204 | 2,439 | 204 | 2,023 | 152 |
NFKB1 | 2,875 | 107 | Nuclear factor kappa B subunit 1 [HGNC:7794] | 730 | 23 | 1,608 | 91 | 1,237 | 37 | 814 | 29 | 716 | 22 | 1,978 | 100 | 2,000 | 101 | 1,742 | 94 |
NOD1 | 1,056 | 51 | Nucleotide binding oligomerization domain containing 1 [HGNC:16390] | – | – | 754 | 43 | – | – | – | – | 409 | 21 | 1,010 | 47 | 1,010 | 49 | 844 | 40 |
NOD2 | 2,578 | 59 | Nucleotide binding oligomerization domain containing 2 [HGNC:5331] | 952 | 23 | 1,629 | 53 | 1,124 | 21 | – | – | 836 | 23 | 2,152 | 57 | 2,165 | 59 | 1,837 | 48 |
NPSR1 | 1,007 | 55 | Neuropeptide S receptor 1 [HGNC:23631] | – | – | 712 | 44 | 554 | 21 | – | – | – | – | 959 | 52 | 956 | 54 | 777 | 50 |
NR3C1 | 925 | 54 | Nuclear receptor subfamily 3 group C member 1 [HGNC:7978] | – | – | 636 | 38 | 692 | 34 | 451 | 25 | – | – | 896 | 54 | 890 | 54 | 659 | 47 |
NR5A1 | 419 | 69 | Nuclear receptor subfamily 5 group A member 1 [HGNC:7983] | 190 | 22 | 285 | 50 | 239 | 29 | – | – | – | – | 408 | 60 | 407 | 64 | 322 | 50 |
OPRK1 | 1,122 | 51 | Opioid receptor kappa 1 [HGNC:8154] | 455 | 29 | 805 | 41 | 564 | 34 | – | – | 428 | 29 | 1,068 | 51 | 1,070 | 50 | 895 | 41 |
PIP4K2A | 1,898 | 88 | Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha [HGNC:8997] | 609 | 31 | 1,082 | 66 | 812 | 34 | – | – | 566 | 23 | 1,486 | 84 | 1,501 | 83 | 1,206 | 72 |
PLA2G7 | 1,907 | 57 | Phospholipase A2 group VII [HGNC:9040] | 828 | 27 | 1,367 | 37 | 995 | 37 | – | – | 737 | 28 | 1,825 | 52 | 1,826 | 51 | 1,534 | 37 |
PLK1 | 1,935 | 108 | Polo like kinase 1 [HGNC:9077] | 631 | 45 | 1,125 | 82 | 836 | 39 | 431 | 23 | 590 | 36 | 1,531 | 100 | 1,542 | 102 | 1,241 | 88 |
POLB | 1,166 | 53 | DNA polymerase beta [HGNC:9174] | 480 | 22 | 850 | 37 | 646 | 30 | – | – | 462 | 21 | 1,113 | 50 | 1,113 | 50 | 932 | 39 |
POLH | 2,202 | 70 | DNA polymerase eta [HGNC:9181] | 858 | 26 | 1,342 | 44 | 1,015 | 37 | – | – | 749 | 23 | 1,827 | 61 | 1,838 | 64 | 1,532 | 48 |
POLI | 1,726 | 79 | DNA polymerase iota [HGNC:9182] | 775 | 29 | 1,210 | 52 | 945 | 43 | 448 | 24 | 689 | 27 | 1,629 | 71 | 1,637 | 72 | 1,359 | 55 |
POLK | 2,895 | 79 | DNA polymerase kappa [HGNC:9183] | 1,248 | 30 | 2,048 | 49 | 1,799 | 43 | 986 | 27 | 1,154 | 26 | 2,713 | 69 | 2,722 | 70 | 2,225 | 54 |
PRMT1 | 2,886 | 80 | Protein arginine methyltransferase 1 [HGNC:5187] | 1,114 | 28 | 1,704 | 59 | 1,073 | 23 | – | – | – | – | 2,394 | 74 | 2,415 | 74 | 2,081 | 68 |
RAD52 | 14,593 | 132 | RAD52 homolog, DNA repair protein [HGNC:9824] | – | – | 2,291 | 25 | – | – | – | – | – | – | 3,043 | 40 | 3,496 | 54 | 3,121 | 49 |
SIRT5 | 14,103 | 141 | Sirtuin 5 [HGNC:14933] | – | – | 2,086 | 30 | – | – | – | – | – | – | 2,769 | 40 | 3,211 | 44 | 2,844 | 42 |
SLC6A3 | 1,006 | 94 | Solute carrier family 6 member 3 [HGNC:11049] | 461 | 49 | 773 | 71 | 584 | 72 | 252 | 54 | 453 | 49 | 976 | 91 | 973 | 90 | 823 | 73 |
SMN2 | 1,633 | 53 | Survival of motor neuron 2, centromeric [HGNC:11118] | – | – | 1,136 | 44 | 1,059 | 28 | – | – | – | – | 1,520 | 49 | 1,521 | 49 | 1,209 | 45 |
STK33 | 3,358 | 423 | Serine/threonine kinase 33 [HGNC:14568] | 1,127 | 101 | 2,077 | 304 | 1,458 | 163 | 776 | 131 | 1,034 | 102 | 2,660 | 329 | 2,663 | 360 | 2,268 | 328 |
TARDBP | 1,802 | 60 | TAR DNA binding protein [HGNC:11571] | – | – | 1,044 | 50 | 748 | 25 | – | – | – | – | 1,409 | 58 | 1,418 | 59 | 1,156 | 52 |
TNFRSF10B | 2,429 | 80 | TNF receptor superfamily member 10b [HGNC:11905] | – | – | 1,510 | 66 | 1,056 | 26 | – | – | 786 | 27 | 2,008 | 73 | 2,021 | 75 | 1,718 | 58 |
TP53 | 2,310 | 198 | Tumor protein p53 [HGNC:11998] | 974 | 97 | 1,554 | 137 | 1,380 | 130 | 737 | 84 | 891 | 98 | 2,172 | 179 | 2,174 | 181 | 1,714 | 137 |
TSHR | 2,259 | 70 | Thyroid stimulating hormone receptor [HGNC:12373] | 968 | 25 | 1,579 | 58 | 1,317 | 43 | 727 | 35 | – | – | 2,133 | 68 | 2,131 | 67 | 1,739 | 64 |
TUBB | 697 | 51 | Tubulin beta class I [HGNC:20778] | – | – | 503 | 32 | 373 | 32 | – | – | – | – | 692 | 48 | 693 | 49 | 563 | 32 |
USP1 | 2,356 | 64 | Ubiquitin specific peptidase 1 [HGNC:12607] | 877 | 30 | 1,425 | 46 | 1,260 | 45 | 697 | 29 | 833 | 30 | 1,972 | 55 | 1,985 | 58 | 1,557 | 44 |
VDR | 2,696 | 140 | Vitamin D receptor [HGNC:12679] | 1,161 | 44 | 1,901 | 101 | 1,673 | 80 | 915 | 50 | 1,076 | 43 | 2,530 | 127 | 2,536 | 128 | 2,059 | 107 |
YES1 | 138 | 101 | YES proto-oncogene 1, Src family tyrosine kinase [HGNC:12841] | 106 | 89 | 99 | 86 | 117 | 89 | 77 | 76 | 106 | 89 | 132 | 97 | 131 | 99 | 90 | 67 |